Risk factors for cardiac implantable electronic device infection: a systematic review and meta-analysis (Q38450566)

3 September 2017

0 references

1 reference

title

Risk factors for cardiac implantable electronic device infection: a systematic review and meta-analysis (English)

1 reference

3 September 2017

1 reference

1 reference

Konstantinos A Polyzos

series ordinal

1

1 reference

3 September 2017

3

Matthew E Falagas

1 reference

3 September 2017

author name string

Athanasios A Konstantelias

series ordinal

2

1 reference

3 September 2017

publication date

1 May 2015

1 reference

3 September 2017

1 reference

3 September 2017

volume

17

1 reference

3 September 2017

issue

5

1 reference

3 September 2017

page(s)

767-777

1 reference

Rising rates of cardiac rhythm management device infections in the United States: 1996 through 2003.

3 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV053

16-year trends in the infection burden for pacemakers and implantable cardioverter-defibrillators in the United States 1993 to 2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV053

Risk factors for mortality in patients with cardiac device-related infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV053

Clinical Predictors of Cardiovascular Implantable Electronic Device‐Related Infective Endocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV053

Mortality and cost associated with cardiovascular implantable electronic device infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV053

Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV053

Cardiac implantable electronic device infections: presentation, management, and patient outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV053

How European centres diagnose, treat, and prevent CIED infections: results of an European Heart Rhythm Association survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV053

Economic implications of infections of implantable cardiac devices in a single institution

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV053

Antibiotic prophylaxis for permanent pacemaker implantation: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV053

Renal insufficiency and the risk of infection from pacemaker or defibrillator surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV053

Pocket hematoma after pacemaker or implantable cardioverter defibrillator surgery: influence of patient morbidity, operation strategy, and perioperative antiplatelet/anticoagulation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV053

Contemporary management of and outcomes from cardiac device related infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV053

Risk factor analysis of permanent pacemaker infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV053

Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV053

Outcome of single-chamber, ventricular pacemakers with transvenous leads implanted in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV053

Permanent pacemaker and implantable cardioverter defibrillator infection: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV053

New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV053

Staphylococcus aureus bacteremia in patients with permanent pacemakers or implantable cardioverter-defibrillators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV053

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV053

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV053

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV053

Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV053

Antibiotic prophylaxis in pacemaker surgery--a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV053

Efficacy of antibiotic prophylaxis before the implantation of pacemakers and cardioverter-defibrillators: results of a large, prospective, randomized, double-blinded, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV053

Antibiotic prophylaxis in permanent pacemaker implantation: a prospective randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV053

Prophylactic antibiotics for cardiac pacemaker implantation. A prospective trail

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV053

Early complications of permanent pacemaker implantation: no difference between dual and single chamber systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV053

Antibiotic prophylaxis with a single dose of cefazolin during pacemaker implantation: incidence of long-term infective complications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV053

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV053

Predictors of Short-Term Complications After Implantable Cardioverter-Defibrillator Replacement

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV053

Clinical significance of device-related complications in clinical trials and implications for future trials: insights from the Antiarrhytmics Versus Implantable Defibrillators (AVID) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV053

Long-term complications related to biventricular defibrillator implantation: rate of surgical revisions and impact on survival: insights from the Italian Clinical Service Database

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV053

Cardiac implantable devices: Surveillance of surgical site infections and assessment of professional practices

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV053

Complications after Single versus Dual Chamber Pacemaker Implantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV053

Prevalence and risk factors related to infections of cardiac resynchronization therapy devices

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV053

Cardiovascular implantable electronic device replacement infections and prevention: results from the REPLACE Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV053

Outcome of advisory implantable cardioverter-defibrillator replacement: one-year follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV053

Risk factors for infection of implantable cardiac devices: data from a registry of 2496 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV053

Risk factors and time delay associated with cardiac device infections: Leiden device registry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV053

Case-control study of surgical site infections associated with pacemakers and implantable cardioverter-defibrillators

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV053

The relation between patients' outcomes and the volume of cardioverter-defibrillator implantation procedures performed by physicians treating Medicare beneficiaries

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV053

Are elderly patients at increased risk of complications following pacemaker implantation? A meta-analysis of randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV053

Implantation success and infection in cardiovascular implantable electronic device procedures utilizing an antibacterial envelope.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV053

Pacemaker infections: a 10-year experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV053

Trends in the Use and Outcomes of Implantable Cardioverter-Defibrillators in Patients Undergoing Dialysis in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV053

Increased complication rates of cardiac rhythm management devices in ESRD patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV053

Infections of implantable cardioverter-defibrillators: frequency, predisposing factors and clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV053

The first year experience with the dual chamber ICD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV053

Infection after pacemaker implantation: infection rates and risk factors associated with infection in a population-based cohort study of 46299 consecutive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV053

Complications Related to Permanent Pacemaker Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV053

Long-term infection rates associated with the pectoral versus abdominal approach to cardioverter- defibrillator implants

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV053

Short-term implantation-related complications of cardiac rhythm management device therapy: a retrospective single-centre 1-year survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV053

Lead complications, device infections, and clinical outcomes in the first year after implantation of cardiac resynchronization therapy-defibrillator and cardiac resynchronization therapy-pacemaker

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV053

End-Stage Renal Disease Predicts Complications in Pacemaker and ICD Implants

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV053

Infections after cardioverter-defibrillator implantation: observations in 335 patients over 10 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV053

Infections in Implantable Cardioverter Defibrillator Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV053

Association of single- vs dual-chamber ICDs with mortality, readmissions, and complications among patients receiving an ICD for primary prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV053

Infrequent physician use of implantable cardioverter-defibrillators risks patient safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV053

2012 EHRA/HRS expert consensus statement on cardiac resynchronization therapy in heart failure: implant and follow-up recommendations and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV053

Use of an antibacterial envelope is associated with reduced cardiac implantable electronic device infections in high-risk patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV053

Cardiac implantable electronic device infections: incidence, risk factors, and the effect of the AigisRx antibacterial envelope.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV053

Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV053

Pacemaker or defibrillator surgery without interruption of anticoagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV053

Management of recalled pacemakers and implantable cardioverter-defibrillators: a decision analysis model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV053

Cardiovascular implantable electronic device infection in patients with Staphylococcus aureus bacteremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV053

Long-term outcomes of cardiovascular implantable electronic devices in patients with Staphylococcus aureus bacteremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV053

Microbiology of cardiac implantable electronic device infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV053

21 January 2018

Identifiers

DOI

10.1093/EUROPACE/EUV053

1 reference

3 September 2017

1 reference